ÂÜÀòÂÒÂ×

Gillian Fairfield serves as the Director and General Counsel at Cancer Research UK since September 2021. In addition, Gillian holds positions as a Board Member at American Friends of Cancer Research Inc since January 2024 and at Cancer Grand Challenges since September 2022. Gillian is also an Investment Committee Trustee at the National Trust for Scotland and a Strategic Advisory Board Member at Cranfield School of Management. Prior roles include General Counsel at Spire Healthcare Group plc, Senior Consultant at Slaughter and May, and Non Executive Director at Lonmin Plc. Gillian's expertise in impact investing was demonstrated at ClearlySo, where leadership in capital raisings and advisory mandates occurred. A former Partner at Herbert Smith Freehills LLP, Gillian holds degrees in Russian from The University of Edinburgh and in law from the College of Law, York.